At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the journey from laboratory discovery to marketable pharmaceutical products hinges on the quality and availability of key chemical intermediates. 4-Amidinobenzamide Hydrochloride, with its distinctive white solid powder form and 98% purity, represents such a vital component. Its utility spans across various stages of pharmaceutical synthesis, making it an indispensable asset for researchers and manufacturers alike.

The development of new therapeutics often involves intricate multi-step syntheses, where each intermediate plays a crucial role. 4-Amidinobenzamide Hydrochloride serves as a valuable building block, contributing to the construction of complex molecular structures that may exhibit therapeutic activity. As a reliable source of pharmaceutical synthesis reagents, our company ensures that these foundational materials are of the highest standard, facilitating consistent and reproducible results in critical research and development pipelines.

In the field of peptide synthesis, the precise formation of amide bonds is essential. While the compound itself may not be a direct coupling reagent, its structural characteristics make it relevant to research in this area, potentially as a precursor or a subject for methodological studies. Advances in amide bond formation techniques are constantly being made, and high-quality intermediates like 4-Amidinobenzamide Hydrochloride are integral to these advancements.

Beyond peptide applications, the compound's utility extends to broader areas of organic synthesis. Its chemical reactivity allows for diverse modifications, making it a versatile player in the creation of novel compounds with potential applications in medicine and beyond. The demand for robust chemical synthesis intermediates is perpetual, and we are dedicated to meeting this need with compounds that offer both quality and versatility.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to empowering innovation in the pharmaceutical industry. By providing access to critical intermediates like 4-Amidinobenzamide Hydrochloride, we aim to accelerate the development of new treatments and improve patient outcomes. Our focus remains on delivering the essential chemical tools that enable groundbreaking discoveries and the production of life-enhancing therapies.